Evidence map›Paper›PMID 27699217›Full record

ArticleJCI insight2016

Perinatal tolerance to proinsulin is sufficient to prevent autoimmune diabetes.

Gaurang Jhala, Jonathan Chee, Prerak M Trivedi, Claudia Selck, Esteban N Gurzov, Kate L Graham, Helen E Thomas, Thomas Wh Kay, Balasubramanian Krishnamurthy

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
33.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 197 citations in OpenAlex.

  1. New Perspectives in Studying Type 1 Diabetes Susceptibility Biomarkers.International journal of molecular sciences · 2025
    Review
  2. Extraislet expression of islet antigen boosts T cell exhaustion to partially prevent autoimmune diabetes.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Gaurang JhalaSt. Vincent's Institute, Fitzroy, Victoria, Australia.
Jonathan CheeThe Harry Perkins Institute of Medical Research, University of Western Australia, Nedlands, Western Australia, Australia.
Prerak M TrivediSt. Vincent's Institute, Fitzroy, Victoria, Australia.
Claudia SelckSt. Vincent's Institute, Fitzroy, Victoria, Australia.
Esteban N GurzovSt. Vincent's Institute, Fitzroy, Victoria, Australia.
Kate L GrahamSt. Vincent's Institute, Fitzroy, Victoria, Australia.
Helen E ThomasSt. Vincent's Institute, Fitzroy, Victoria, Australia.
Thomas Wh KaySt. Vincent's Institute, Fitzroy, Victoria, Australia.
Balasubramanian KrishnamurthySt. Vincent's Institute, Fitzroy, Victoria, Australia.
St Vincents Institute of Medical Research · AUSt Vincent's Hospital · AUUniversity of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-affinity self-reactive thymocytes are purged in the thymus, and residual self-reactive T cells, which are detectable in healthy subjects, are controlled by peripheral tolerance mechanisms. Breakdown in these mechanisms results in autoimmune disease, but antigen-specific therapy to augment natural mechanisms can prevent this. We aimed to determine when antigen-specific therapy is most effective. Islet autoantigens, proinsulin (PI), and islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP) were expressed in the antigen-presenting cells (APCs) of autoimmune diabetes-prone nonobese diabetic (NOD) mice in a temporally controlled manner. PI expression from gestation until weaning was sufficient to completely protect NOD mice from diabetes, insulitis, and development of insulin autoantibodies. Insulin-specific T cells were significantly diminished, were naive, and did not express IFN-γ when challenged. This long-lasting effect from a brief period of treatment suggests that autoreactive T cells are not produced subsequently. We tracked IGRP

Indexed as

AnimalsAntigen-Presenting CellsAutoantigensCD8-Positive T-LymphocytesDiabetes Mellitus, Type 1Glucose-6-PhosphataseImmune ToleranceMiceMice, Inbred C57BLMice, Inbred NODMice, TransgenicProinsulinAutoantigensG6pc2 protein, mouseGlucose-6-PhosphataseProinsulin

Identifiers

PMID27699217
PMCPMC5033903
OpenAlexW2475189158

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.